Cargando…

Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy

Detalles Bibliográficos
Autores principales:	Chen, Liyu, Liu, Yanbin, Wang, Weiya, Liu, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968002/ https://www.ncbi.nlm.nih.gov/pubmed/33747207 http://dx.doi.org/10.3892/ol.2021.12611

Ejemplares similares

Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer
por: Wang, Rong-Hua, et al.
Publicado: (2017)

Retracted: Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
por: BioMed Research International,
Publicado: (2018)

miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma
por: Liu, Yahui, et al.
Publicado: (2022)

MicroRNA-744 inhibits migration and invasion of hepatocellular carcinoma cells by targeting SOX12
por: Zhang, Wei, et al.
Publicado: (2022)

miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN
por: Liu, Kai, et al.
Publicado: (2022)

Retracted: Effect of Paclitaxel Combined with Doxorubicin Hydrochloride Liposome Injection in the Treatment of Osteosarcoma and MRI Changes before and after Treatment
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

MiR-132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3
por: Liu, Kai, et al.
Publicado: (2021)

Retracted: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target
por: International, BioMed Research
Publicado: (2021)

MicroRNA-466 inhibits the aggressive behaviors of hepatocellular carcinoma by directly targeting metadherin
por: Jia, Chen, et al.
Publicado: (2022)

Retracted: Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma Diagnosis Research
por: International, BioMed Research
Publicado: (2023)

[Retracted] miR‑365 induces hepatocellular carcinoma cell apoptosis through targeting Bcl‑2
por: Li, Mingfei, et al.
Publicado: (2023)

Retraction Note: Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stability
por: Lin, Zhikun, et al.
Publicado: (2023)

MicroRNA-148a inhibits the proliferation and promotes the paclitaxel-induced apoptosis of ovarian cancer cells by targeting PDIA3
por: Zhao, Shuzhen, et al.
Publicado: (2021)

MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1
por: Ye, Ying, et al.
Publicado: (2022)

[Retracted] MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2023)

Retraction: miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3
Publicado: (2017)

Retraction: Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway
Publicado: (2023)

Retraction: Alpha-Fetoprotein Promoter-Driven Cre/LoxP-Switched RNA Interference for Hepatocellular Carcinoma Tissue-Specific Target Therapy
Publicado: (2023)

Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1 [Retraction]
Publicado: (2021)

miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction
por: Wang, Liang, et al.
Publicado: (2022)

A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction]
Publicado: (2022)

[Retracted] MicroRNA‑526a targets p21‑activated kinase 7 to inhibit tumorigenesis in hepatocellular carcinoma
por: Zhan, Lei, et al.
Publicado: (2023)

miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor
por: Pang, Xiaoli, et al.
Publicado: (2021)

Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy
por: Zheng, Yanwen, et al.
Publicado: (2021)

Retracted: Facile Synthesis of NaYF4:Yb Up-Conversion Nanoparticles Modified with Photosensitizer and Targeting Antibody for In Vitro Photodynamic Therapy of Hepatocellular Carcinoma
por: Healthcare Engineering, Journal of
Publicado: (2023)

MicroRNA-19a promotes nasopharyngeal carcinoma by targeting transforming growth factor β receptor 2
por: Ma, Fang, et al.
Publicado: (2021)

MiR-144 Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting SMAD4 [Retraction]
Publicado: (2021)

MicroRNA-212 Inhibits Hepatocellular Carcinoma Cell Proliferation and Induces Apoptosis by Targeting FOXA1 [Retraction]
Publicado: (2022)

[Retracted] microRNA‑196b promotes cell migration and invasion by targeting FOXP2 in hepatocellular carcinoma
por: Yu, Zhaoxiang, et al.
Publicado: (2023)

miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
por: Liu, Kai, et al.
Publicado: (2021)

Dual Targeting Biomimetic Liposomes for Paclitaxel/DNA Combination Cancer Treatment
por: Liu, Guo-Xia, et al.
Publicado: (2014)

Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes
por: Gross, Nikolai, et al.
Publicado: (2013)

MiR-502-3P Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting SET [Retraction]
Publicado: (2021)

MicroRNA-548b inhibits proliferation and invasion of hepatocellular carcinoma cells by directly targeting specificity protein 1
por: Qiu, Haile, et al.
Publicado: (2022)

Retraction: The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression
Publicado: (2023)

Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Zhou, Xiaoju, et al.
Publicado: (2012)

Synergistic effects of co-expression plasmid-based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo
por: Liu, Songyang, et al.
Publicado: (2022)

Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Retraction]
Publicado: (2022)

MicroRNA-601 serves as a potential tumor suppressor in hepatocellular carcinoma by directly targeting PIK3R3
por: Song, Yanan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_od4i7smq86m149k3s0dodtklvc